Global Bacteriophage Therapy Market Size, Share, Growth Analysis Report - Forecast 2034
Bacteriophage Therapy Market By Target (Escherichia Coli, Staphylococcus, Streptococcus, Pseudomonas, Salmonella, Others), By Type (Lytic, Lysogenic, Base), Base (Sterile Broth Culture, Water-Soluble Jelly Base), Application (Bacterial Dysentery, Infections of Skin And Nasal Mucosa, Suppurative Skin Infection, Lung and Pleural Infections, Postoperative Wound Infections, Others), Route of Administration (Oral, Parenteral, Rectal, Dermal, Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 282 Report Code: ZMR-7082
Published Date: May-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 86.73 Million | USD 191.8 Million | 8.26% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Bacteriophage Therapy Market, (2022 - 2030) (USD Million)
- 2.2 Global Bacteriophage Therapy Market : snapshot
- Chapter 3. Global Bacteriophage Therapy Market - Industry Analysis
- 3.1 Bacteriophage Therapy Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Massive application of bacteria for removing biofilms to boost the global bacteriophage therapy industry expansion
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.4.1. Effectiveness of bacteriophage treatment against antibiotic-resisting microbes and pathogens to generate new growth opportunities for the global market
- 3.5 Market Challenges
- 3.5.1. Low raw material supply for manufacturing drugs due to irregular transportation has proved to be a major challenge for growth of the global market
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product
- 3.7.2 Market attractiveness analysis By Route of Administration
- 3.7.3 Market attractiveness analysis By Application
- Chapter 4. Global Bacteriophage Therapy Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Bacteriophage Therapy Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Bacteriophage Therapy Market - Product Analysis
- 5.1 Global Bacteriophage Therapy Market overview: By Product
- 5.1.1 Global Bacteriophage Therapy Market share, By Product, 2021 and 2030
- 5.2 Phage Probiotics
- 5.2.1 Global Bacteriophage Therapy Market by Phage Probiotics, 2022 - 2030 (USD Million)
- 5.3 Phage Therapeutic
- 5.3.1 Global Bacteriophage Therapy Market by Phage Therapeutic, 2022 - 2030 (USD Million)
- 5.1 Global Bacteriophage Therapy Market overview: By Product
- Chapter 6. Global Bacteriophage Therapy Market - Route of Administration Analysis
- 6.1 Global Bacteriophage Therapy Market overview: By Route of Administration
- 6.1.1 Global Bacteriophage Therapy Market share, By Route of Administration, 2021 and 2030
- 6.2 Oral
- 6.2.1 Global Bacteriophage Therapy Market by Oral, 2022 - 2030 (USD Million)
- 6.3 Topical
- 6.3.1 Global Bacteriophage Therapy Market by Topical, 2022 - 2030 (USD Million)
- 6.1 Global Bacteriophage Therapy Market overview: By Route of Administration
- Chapter 7. Global Bacteriophage Therapy Market - Application Analysis
- 7.1 Global Bacteriophage Therapy Market overview: By Application
- 7.1.1 Global Bacteriophage Therapy Market share, By Application, 2021 and 2030
- 7.2 Skin Infection Treatment
- 7.2.1 Global Bacteriophage Therapy Market by Skin Infection Treatment, 2022 - 2030 (USD Million)
- 7.3 Gastroenterology
- 7.3.1 Global Bacteriophage Therapy Market by Gastroenterology, 2022 - 2030 (USD Million)
- 7.4 Wound Prophylaxis
- 7.4.1 Global Bacteriophage Therapy Market by Wound Prophylaxis, 2022 - 2030 (USD Million)
- 7.5 Respiratory Infections Treatment
- 7.5.1 Global Bacteriophage Therapy Market by Respiratory Infections Treatment, 2022 - 2030 (USD Million)
- 7.6 Urogenital Infection Treatment
- 7.6.1 Global Bacteriophage Therapy Market by Urogenital Infection Treatment, 2022 - 2030 (USD Million)
- 7.1 Global Bacteriophage Therapy Market overview: By Application
- Chapter 8. Bacteriophage Therapy Market - Regional Analysis
- 8.1 Global Bacteriophage Therapy Market Regional Overview
- 8.2 Global Bacteriophage Therapy Market Share, by Region, 2021 & 2030 (USD Million)
- 8.3. North America
- 8.3.1 North America Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.3.1.1 North America Bacteriophage Therapy Market, by Country, 2022 - 2030 (USD Million)
- 8.3.1 North America Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.4 North America Bacteriophage Therapy Market, by Product, 2022 - 2030
- 8.4.1 North America Bacteriophage Therapy Market, by Product, 2022 - 2030 (USD Million)
- 8.5 North America Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030
- 8.5.1 North America Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030 (USD Million)
- 8.6 North America Bacteriophage Therapy Market, by Application, 2022 - 2030
- 8.6.1 North America Bacteriophage Therapy Market, by Application, 2022 - 2030 (USD Million)
- 8.4. Europe
- 8.4.2 Europe Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.4.2.1 Europe Bacteriophage Therapy Market, by Country, 2022 - 2030 (USD Million)
- 8.4.2 Europe Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.4 Europe Bacteriophage Therapy Market, by Product, 2022 - 2030
- 8.4.1 Europe Bacteriophage Therapy Market, by Product, 2022 - 2030 (USD Million)
- 8.5 Europe Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030
- 8.5.1 Europe Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030 (USD Million)
- 8.6 Europe Bacteriophage Therapy Market, by Application, 2022 - 2030
- 8.6.1 Europe Bacteriophage Therapy Market, by Application, 2022 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.5.3.1 Asia Pacific Bacteriophage Therapy Market, by Country, 2022 - 2030 (USD Million)
- 8.5.3 Asia Pacific Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.4 Asia Pacific Bacteriophage Therapy Market, by Product, 2022 - 2030
- 8.4.1 Asia Pacific Bacteriophage Therapy Market, by Product, 2022 - 2030 (USD Million)
- 8.5 Asia Pacific Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030
- 8.5.1 Asia Pacific Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030 (USD Million)
- 8.6 Asia Pacific Bacteriophage Therapy Market, by Application, 2022 - 2030
- 8.6.1 Asia Pacific Bacteriophage Therapy Market, by Application, 2022 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.4 Latin America Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.6.4.1 Latin America Bacteriophage Therapy Market, by Country, 2022 - 2030 (USD Million)
- 8.6.4 Latin America Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.4 Latin America Bacteriophage Therapy Market, by Product, 2022 - 2030
- 8.4.1 Latin America Bacteriophage Therapy Market, by Product, 2022 - 2030 (USD Million)
- 8.5 Latin America Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030
- 8.5.1 Latin America Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030 (USD Million)
- 8.6 Latin America Bacteriophage Therapy Market, by Application, 2022 - 2030
- 8.6.1 Latin America Bacteriophage Therapy Market, by Application, 2022 - 2030 (USD Million)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.7.5.1 The Middle-East and Africa Bacteriophage Therapy Market, by Country, 2022 - 2030 (USD Million)
- 8.7.5 The Middle-East and Africa Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 8.4 The Middle-East and Africa Bacteriophage Therapy Market, by Product, 2022 - 2030
- 8.4.1 The Middle-East and Africa Bacteriophage Therapy Market, by Product, 2022 - 2030 (USD Million)
- 8.5 The Middle-East and Africa Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030
- 8.5.1 The Middle-East and Africa Bacteriophage Therapy Market, by Route of Administration, 2022 - 2030 (USD Million)
- 8.6 The Middle-East and Africa Bacteriophage Therapy Market, by Application, 2022 - 2030
- 8.6.1 The Middle-East and Africa Bacteriophage Therapy Market, by Application, 2022 - 2030 (USD Million)
- Chapter 9. Company Profiles
- 9.1 PhagePro Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Enbiotix Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 TechnoPhage SA
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Eligo Bioscience SA
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Armata Pharmaceuticals Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 ContraFect Corporation
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Phagomed Biopharma GmbH.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Eliava Biopreparations Ltd.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Fixed-phage Ltd.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Intodeworld Inc.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Pherecydes Pharma
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 BiomX Ltd.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Adaptive Phage Therapeutics
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Intralytix Inc.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Phagelux Inc.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Nextbiotics
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 InnoPhage Ltd
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Phi Therapeutics
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Locus Biosciences Inc.
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Micreos BV
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 OPTIPHARM Co. Ltd.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 PhagePro Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global Bacteriophage Therapy Market attractiveness, By Product
- 6. Global Bacteriophage Therapy Market attractiveness, By Route of Administration
- 7. Global Bacteriophage Therapy Market attractiveness, By Application
- 8. Global Bacteriophage Therapy Market share by Product, 2022 and 2030 (USD Million)
- 9. Global Bacteriophage Therapy Market by Phage Probiotics, 2022 - 2030 (USD Million)
- 10. Global Bacteriophage Therapy Market by Phage Therapeutic, 2022 - 2030 (USD Million)
- 11. Global Bacteriophage Therapy Market share by Route of Administration, 2022 and 2030 (USD Million)
- 12. Global Bacteriophage Therapy Market by Oral, 2022 - 2030 (USD Million)
- 13. Global Bacteriophage Therapy Market by Topical, 2022 - 2030 (USD Million)
- 14. Global Bacteriophage Therapy Market share by Application, 2022 and 2030 (USD Million)
- 15. Global Bacteriophage Therapy Market by Skin Infection Treatment, 2022 - 2030 (USD Million)
- 16. Global Bacteriophage Therapy Market by Gastroenterology, 2022 - 2030 (USD Million)
- 17. Global Bacteriophage Therapy Market by Wound Prophylaxis, 2022 - 2030 (USD Million)
- 18. Global Bacteriophage Therapy Market by Respiratory Infections Treatment, 2022 - 2030 (USD Million)
- 19. Global Bacteriophage Therapy Market by Urogenital Infection Treatment, 2022 - 2030 (USD Million)
- 20. Global Bacteriophage Therapy Market share, by Region, 2022 and 2030
- 21. North America Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 22. Europe Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 23. Asia Pacific Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 24. Latin America Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
- 25. The Middle-East and Africa Bacteriophage Therapy Market, 2022 - 2030 (USD Million)
Table Of Tables
- 1. Global Bacteriophage Therapy Market: Snapshot
- 2. Drivers of the Bacteriophage Therapy Market: impact analysis
- 3. North America Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 4. North America Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 5. North America Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 6. U.S. Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 7. U.S. Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 8. U.S. Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 9. Canada Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 10. Canada Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 11. Canada Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 12. Europe Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 13. Europe Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 14. Europe Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 15. Germany Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 16. Germany Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 17. Germany Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 18. France Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 19. France Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 20. France Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 21. U.K. Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 22. U.K. Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 23. U.K. Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 24. Italy Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 25. Italy Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 26. Italy Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 27. Spain Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 28. Spain Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 29. Spain Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 30. Rest of Europe Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 31. Rest of Europe Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 32. Rest of Europe Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 33. Asia Pacific Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 34. Asia Pacific Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 35. Asia Pacific Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 36. China Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 37. China Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 38. China Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 39. Japan Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 40. Japan Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 41. Japan Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 42. India Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 43. India Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 44. India Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 45. South Korea Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 46. South Korea Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 47. South Korea Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 48. South-East Asia Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 49. South-East Asia Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 50. South-East Asia Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 51. Rest of Asia Pacific Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 52. Rest of Asia Pacific Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 53. Rest of Asia Pacific Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 54. Latin America Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 55. Latin America Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 56. Latin America Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 57. Brazil Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 58. Brazil Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 59. Brazil Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 60. Mexico Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 61. Mexico Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 62. Mexico Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 63. Rest of Latin America Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 64. Rest of Latin America Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 65. Rest of Latin America Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 66. The Middle-East and Africa Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 67. The Middle-East and Africa Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 68. The Middle-East and Africa Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 69. GCC Countries Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 70. GCC Countries Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 71. GCC Countries Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 72. South Africa Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 73. South Africa Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 74. South Africa Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
- 75. Rest of Middle-East Africa Bacteriophage Therapy Market revenue, By Product, 2022 - 2030 (USD Million)
- 76. Rest of Middle-East Africa Bacteriophage Therapy Market revenue, By Route of Administration, 2022 - 2030 (USD Million)
- 77. Rest of Middle-East Africa Bacteriophage Therapy Market revenue, By Application, 2022 - 2030 (USD Million)
Methodology
FrequentlyAsked Questions
The global bacteriophage therapy market is expected to grow due to rising prevalence of antibiotic-resistant bacteria, increasing research and development activities, growing investments in healthcare infrastructure.
According to a study, the global bacteriophage therapy market size was worth around USD 86.73 Million in 2024 and is expected to reach USD 191.8 Million by 2034.
The global bacteriophage therapy market is expected to grow at a CAGR of 8.26% during the forecast period.
North America is expected to dominate the bacteriophage therapy market over the forecast period.
Leading players in the global bacteriophage therapy market include Microgen (U.S.), Micreos (Netherlands), ATCC (U.S.), Intralytix Inc. (U.S.), Adaptive Phage Therapeutics (U.S.), Armata pharmaceuticals Inc. (U.S.), LOCUS BIOSCIENCES Inc. (U.S.), Delmont Laboratories Inc. (U.S.), Nextbiotics (U.S.), Pherecydes Pharma (France), iNtODEWORLD. Inc. (U.S.), Enbiotix (U.S.), Fixed-Phage Limited (U.K.), Cytophage Technologies Inc. (Canada), Eliava Bio Preparations LTD (Georgia), Phagelux Inc. (China), InnoPhage, Ltd (Hong Kong), TechnoPhage (Portugal), Eligo Bioscience SA (France), BiomX Ltd. (Israel), among others.
The report explores crucial aspects of the bacteriophage therapy market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
